SCHEMBL8522266

SCHEMBL8522266

CCCCCn1c(N)nc2[nH]cnc2c1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 3/20 0.51
PNP P00491 1/20 0.46
PDE4A P27815 5/20 0.45
ADORA2A P29274 5/20 0.45
PDE4B Q07343 5/20 0.45
PDE4C Q08493 5/20 0.45
PDE4D Q08499 5/20 0.45
ADORA3 P0DMS8 1/20 0.45
TLR8 Q9NR97 7/20 0.44
USP2 O75604 3/20 0.44
POLB P06746 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KEAP1 Q14145 2/20 0.44
NFE2L2 Q16236 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MAPT P10636 1/20 0.44
HTT P42858 1/20 0.44
PKM P14618 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4384737 0.99 ADORA2B (0.53) ADORA2BPNPPDE4AADORA2APDE4B
SCHEMBL8536000 0.99 ADORA2B (0.53) ADORA2BPNPPDE4AADORA2APDE4B
SCHEMBL6272293 0.99 ADORA2B (0.53) ADORA2BPNPPDE4AADORA2APDE4B
Hydrochloric Acid SCHEMBL258895 0.97 ADORA2B (0.52) ADORA2BPNPPDE4AADORA2APDE4B
SCHEMBL6272726 0.96 PDE4A (0.49) ADORA2BPNPPDE4AADORA2APDE4B
Acetic Acid SCHEMBL4280715 0.93 ADORA2B (0.48) ADORA2BPNPPDE4AADORA2APDE4B
SCHEMBL667794 0.90 PDE4A (0.49) ADORA2BPDE4AADORA2APDE4BPDE4C
SCHEMBL8196740 0.88 ADORA2B (0.37) ADORA2BPNPPDE4AADORA2APDE4B
SCHEMBL874734 0.84 ADORA2A (0.45) ADORA2BPNPPDE4AADORA2APDE4B
SCHEMBL3671337 0.82 PNP (0.37) ADORA2BPNPPDE4AADORA2APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116234585-A Microtubule-associated protein TAU (MAPT) iRNA agent compositions and methods of use thereof 阿尔尼拉姆医药品有限公司 2023-06-06 CN disclosed
CN-115298312-A Leucine-rich repeat kinase 2 (LRRK 2) iRNA agent compositions and methods of use thereof 阿尔尼拉姆医药品有限公司 2022-11-04 CN disclosed
CN-114796255-A Application of nicotinamide mononucleotide in protecting liver from being damaged 深圳市旷逸生物科技有限公司 2022-07-29 CN disclosed
CN-114728018-A Huntington (HTT) iRNA pharmaceutical compositions and methods of use thereof 阿尔尼拉姆医药品有限公司 2022-07-08 CN disclosed
EP-0704445-B1 Preparation of N-9 substituted guanine compounds HOFFMANN LA ROCHE (CH) 1999-04-21 EP disclosed
US-5565565-A Preparation of N-9 substituted guanine compounds SYNTEX (U.S.A.) INC. (US) 1996-10-15 US disclosed
EP-0704445-A1 Preparation of N-9 substituted guanine compounds F. Hoffmann-La Roche AG (CH) 1996-04-03 EP disclosed
EP-0590361-A1 Process for the preparation of 2-amino-6-halopurines BASF Aktiengesellschaft (DE) 1994-04-06 EP disclosed
US-4914131-A HERPES SIMPLEX VIRUS; LIDOCAINE OR ITS SALTS Brigham, Dana P. (US) 1990-04-03 US disclosed
US-4757088-A Administering lidocaine and pantothenic acid; herpes Brigham, Dana P. (US) 1988-07-12 US disclosed
US-4628063-A LIDOCAINE, PANTOTHENOL, HERPES Brigham, Dana P. (US) 1986-12-09 US disclosed